(Overview by Solution)Life Science

Growth Strategy

Contributing to the development of healthcare and improvement in QOL with one-of-a-kind products

Yutaka Ouchi

Yutaka Ouchi
Director & Managing Executive Officer
Head of Life Science Solutions

The mission of the Life Science Solutions Division is to consistently “create the solutions for people and the earth” in the healthcare and life science field. Based on our bio- and membrane technologies, we strive to find solutions for the issues faced by users and society, through the fusion and synergy of diverse technologies.

In the diagnostic reagent business, we bring our long-standing expertise in research reagents, to contribute in improving public health, with a focus on developing gene testing agents and their associated materials for a variety of infectious diseases. We are also expanding our lineup of highly functional antibodies for immunity testing agent materials.

In the pharmaceuticals business, we specialize in contract manufacturing of sterile injections to meet growing demand, where our strengths lie in compliance with regulations in Europe, the United States and Japan.

In the medical membranes field, we are improving our manufacturing technology and developing a new business model for active use in areas including hemodialysis, blood purification and antibody drug processes.

In the medical equipment field, we are working hard to expand sales of regenerative medical materials, aiming for standardized treatment. Moreover, we are accelerating research and development by utilizing products from our other businesses as well as employing external expertise.

Through these strategies, we develop and provide “one-of-a-kind” products that our competitors are unable to emulate, thereby contributing to the development of healthcare and improvement in quality of life (QOL).

Future Vision

  • Top domestic provider of solutions for genetic diagnoses of infectious diseases
  • Global-leading medical membrane manufacturer

<Key Products>
Bioproducts (research reagents, diagnostic systems, raw materials for diagnostic applications), pharmaceutical products (contract manufacturing of injections, etc.), medical equipment (nerve regeneration inducing materials, bone regeneration inducing materials, biocompatible polymers), medical membranes (artificial kidney hollow fiber membrane, hollow fiber membrane for blood purification, virus-removing hollow fiber membrane for antibody drug processes)

Value Creation Flow

Process ESG aspects ■ Management base
Enhancement of positive effects (increasing opportunities)
Enhancement of positive effects (increasing opportunities)
Mitigation of negative effects (reducing risk)
Mitigation of negative effects
(reducing risk)
Related material issues
Procurement

Quality and customer health & safetyQuality and customer health & safety

  • Acceptance testing based on GMP (Pharmaceuticals)
  • Ensuring complete traceability of raw materials in products intended for implant

Safety, disaster prevention, quality

Manufacturing

Worker health & safetyWorker health & safety

  • Conducting prior reviews concerning the safety of chemical substances

Safety, disaster prevention, quality

Quality and customer health & safetyQuality and customer health & safety

  • Strict controls based on GMP (Pharmaceuticals)

Safety, disaster prevention, quality

Preventing climate changePreventing climate change

  • Promoting energy conservation by upgrading to highly efficient equipment (Medical Membranes)

Reducing greenhouse gas emissions

Resource circulationResource circulation

  • Collecting offcuts, etc. and providing these to manufacturers that regenerate raw materials (Pharmaceutical Membranes)
  • Reducing packaging material volumes by simplifying packaging (Medical Equipment)

Product life cycle management

Sales / Use

Solutions for customer and social issuesSolutions for customer and social issues

  • Enhancing QOL through our contributions to medical settings Nerve regeneration conduit Nerbridge®
    Artificial kidney hollow fiber membranes
    Fully automated gene analysis system GENECUBE®
    Sterile injections, etc.
SDGs3 SDGs12

Ability to provide solutions (contribution through our business)

Quality and customer health & safetyQuality and customer health & safety

  • Formation of scientific support group to prevent incorrect use of products (Medical Equipment)

Safety, disaster prevention, quality

Disposal / Re-use

Chemical substances managementChemical substances management

  • Selection of specified collection contractors for organic solvents, etc. (Medical Equipment)

Reducing environmental impact

Worker health & safetyWorker health & safety

  • Installation of exhaust ducts at sites where organic solvents are handled (Medical Equipment)

Safety, disaster prevention, quality

Health & safety of local residentsHealth & safety of local residents

  • Outsourcing of waste material processing to specialist operators (Medical Equipment)

Safety, disaster prevention, quality


Reducing environmental impact

Major ESG Topics in Business Processes

Resource circulation

In the medical membrane field, we collect offcuts during manufacturing and provide these to manufacturers that regenerate raw materials, realizing resource circulation. In the medical equipment field, wherever possible we simplify packaging at the point of sales to avoid wasting resources, while always ensuring quality.

Health & safety

In the pharmaceuticals field, besides implementing GMP control measures, we carry out product-specific initiatives in each area. For example, in the medical equipment field, we ensure complete traceability of raw materials in products intended for implant. The scientific support group also trains users to prevent incorrect use.

Value Provided Through Products and Services

Enzymes and analysis systems supporting diagnostics

To contribute to the health of people worldwide, we supply diagnostic-use enzymes to diagnostic reagent manufacturers for use in biochemical diagnosis.

We also provide the fully automated gene analysis system GENECUBE®, which uses our unique high-speed nucleic acid amplification technology to simplify and shorten the process from nucleic acid extraction to amplification and detection. This helps to reduce treatment times and cut drug costs.

Reagents aiding research into SARS-CoV-2

Employing our unique enzymes, SARS-CoV-2 Detection Kit enables the genetic extraction process to be completed in as little as two minutes.

By optimizing the enzyme action through the preparation of a reagent compound, the time taken to amplify the extracted genes has been cut by more than half. The process from extraction to measurement can be completed in under 60 minutes.

Medical equipment promoting regeneration of peripheral nerves

Nerbridge

Nerbridge®

The nerve regeneration conduit Nerbridge® is a device that promotes the regeneration of peripheral nerves severed or damaged as a result of an injury or related causes. It is the first treatment device to obtain approval in Japan using this technology. There is no need to harvest undamaged nerves, unlike in conventional treatment, which shortens surgery time and helps to reduce the burden on the patient. After nerve regeneration, the product is dissolved and absorbed safely by the patient’s body.

Hollow fiber membranes helping to improve dialysis patients’ treatment and QOL

Dialyzer for artificial kidney using a hollow fiber membrane

Dialyzer for artificial kidney using a hollow fiber membrane

Toyobo provides artificial kidney hollow fiber membranes with the aim of improving treatment results for dialysis patients and their quality of life (QOL). Our membranes boast outstanding filtering performance and stable waste removal performance, with little degradation over time, while also demonstrating superior biocompatibility.